Companies / Protalix BioTherapeutics, Inc.

Protalix BioTherapeutics, Inc.

NYSE: PLXCIK 1006281HACKENSACK, NJ

Financials · FY2025

Revenue$52.74M
Net income$-6.60M
Total debt$912.0K
Cash$27.42M
Diluted EPS$-0.08
Shares outstanding80.6M

Ownership

80.6M shares outstanding · as of Aug 1, 2026
4.5%10%+ / strategic
Ownership
10%+ / strategic4.49%3,616,289
Institutions24.15%19,454,122
Public float71.37%57,501,231

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 1

View all →
Insider% of sharesShares
Mamlok GiladSr. VP and CFO
——

Institutional holders 92

View all →
HolderValue% of shares
BlackRock, Inc.$9.43M5.02%
Mak Capital One LLC$7.69M4.40%
Opaleye Management Inc.$4.46M3.08%
Renaissance Technologies LLC$2.66M1.52%
State Street Corporation$2.29M1.22%
Geode Capital Management, LLC$1.88M1.07%
Northern Trust Corp$1.56M1.07%
Stratos Wealth Partners, LTD.$900.0K0.62%
Vanguard Group Inc$879.4K0.61%
Citadel Advisors LLC$571.7K0.39%

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Mak Capital One LLC
13F manager
New—$7.69M+3.5M
3,544,139
4.40% of shares
medium
Q2 2026
as of
BlackRock, Inc.
13F manager
Add—$930.9K+400K
+10.96%
4,046,650
5.02% of shares
low
Q2 2026
as of
State Street Corporation
13F manager
Add—$928.1K+398K
+68.06%
983,582
1.22% of shares
low
Q2 2026
as of
Deutsche Bank AG
13F manager
Add—$178.7K+77K
+9065.13%
77,537
0.10% of shares
low
Q2 2025
as of
Barclays PLC
13F manager
Add—$151.9K+103K
+422.27%
126,963
0.16% of shares
low
Q4 2023
as of
Barclays PLC
13F manager
Add—$141.0K+79K
+170.26%
125,702
0.16% of shares
low
Q2 2026
as of
WINTON GROUP Ltd
13F manager
New—$130.5K+56K
56,001
0.07% of shares
low
Q1 2026
as of
Renaissance Technologies LLC
13F manager
Trim—$-83.5K-39K
-3.05%
1,224,800
1.52% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
MAK Capital Fund LPPassive13G/A—3,616,289—
MAK Capital Fund LPPassive13G—4,649,599—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
PLX——74365A309—